speb/financial-data huggingface dataset:
Financial ratios for ATS — quarterly report dated 2025-06-30
Total revenue: 537751824.8175182
Gross profit: 160474452.5547445
Operating income: 43997080.2919708
Net income: 17712408.759124085
Capital expenditures: 5111678.832116788
Operating cash flow: 113709489.05109487
Depreciation & amortization: 27236496.35036496
Net tangible assets: -299183211.6788321
Owner earnings: 39837226.277372256
Return on net tangible assets (%): -13.3153281074263
Capex to operating income (%): 11.61822284159533
Buffett classification: The Great
Stock price: 31.88
P/E ratio: 43.65001127482074
Shares outstanding: 97007132
Book value: 1247459854.0145986
P/B ratio: 2.479107730968157
Market cap (USD): 3092587368.16
Debt to equity: 0.8889732127184
Current ratio: 1.6155862167330708
Quick ratio: 1.3242663493785296
Effective tax rate (%): 24.50376454483231
Interest coverage ratio: 2.338363657524149
COGS to revenue (%): 70.15826908459115
SG&A to revenue (%): 21.6600608100771
Free cash flow (dilution-adjusted): 98629927.00729927
Buyback yield (%): 0.23602470048681456
Retained earnings: 492390510.94890505
Inventory turnover: 1.664857517417759
Receivables turnover: 0.6573842403389358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8031045490129678
FCF margin (%): 18.341160820936043
Revenue growth (%): 33.91260674714077
Rule of 40 score: 52.25376756807681
Financial ratios for ATS — quarterly report dated 2025-09-30
Total revenue: 524069064.7482015
Gross profit: 156744604.31654677
Operating income: 54131654.676258996
Net income: 24229496.4028777
Capital expenditures: 5828057.553956835
Operating cash flow: 20497122.302158274
Depreciation & amortization: 28367625.899280578
Net tangible assets: -270138129.4964029
Owner earnings: 46769064.748201445
Return on net tangible assets (%): -17.31301865286078
Capex to operating income (%): 10.766450035219224
Buffett classification: The Great
Stock price: 26.2
P/E ratio: 26.2240990912438
Shares outstanding: 97007132
Book value: 1274120863.3093529
P/B ratio: 1.9947768940841133
Market cap (USD): 2541586858.4
Debt to equity: 0.8670292056365001
Current ratio: 1.6297226487567722
Quick ratio: 1.3375920972893667
Effective tax rate (%): 33.82254574070431
Interest coverage ratio: 3.063515329180408
COGS to revenue (%): 70.09084968755835
SG&A to revenue (%): 19.58004326960036
Free cash flow (dilution-adjusted): 9797122.302158274
Buyback yield (%): 0.27219158726158416
Retained earnings: 509535251.7985612
Inventory turnover: 1.592738514137406
Receivables turnover: 0.6229804294505811
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2115964273736752
FCF margin (%): 1.869433431806451
Revenue growth (%): -2.5444376825610733
Rule of 40 score: -0.6750042507546223
Financial ratios for ATS — quarterly report dated 2025-12-31
Total revenue: 555221167.8832116
Gross profit: 164140875.91240874
Operating income: 46119708.029197074
Net income: 21921897.810218975
Capital expenditures: 4520437.956204379
Operating cash flow: 83655474.45255473
Depreciation & amortization: 29418978.10218978
Net tangible assets: -236187591.2408759
Owner earnings: 46820437.95620438
Return on net tangible assets (%): -19.82341142911888
Capex to operating income (%): 9.801532033426184
Buffett classification: The Great
Stock price: 27.54
P/E ratio: 170.04111637101295
Shares outstanding: 97007132
Book value: 1300391240.8759124
P/B ratio: 2.0544404878338693
Market cap (USD): 2671576415.2799997
Debt to equity: 0.8409024572054676
Current ratio: 1.651835009298788
Quick ratio: 1.3714738305546155
Effective tax rate (%): 10.730315370210743
Interest coverage ratio: 2.604129744879034
COGS to revenue (%): 70.4368483395188
SG&A to revenue (%): 21.256604522693003
Free cash flow (dilution-adjusted): 69520437.95620437
Buyback yield (%): 0
Retained earnings: 538832116.7883211
Inventory turnover: 1.7387776825817174
Receivables turnover: 0.6519813933395562
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8672912249074611
FCF margin (%): 12.521215324201707
Revenue growth (%): 5.9442743772669955
Rule of 40 score: 18.4654897014687
Financial ratios for AUX.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.18110236220472442
Shares outstanding: 76655311
Market cap (USD): 13882457.897637796
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -72651.47058823529
Net income: 1692255.1470588234
Capital expenditures: 0
Operating cash flow: -68645.58823529411
Net tangible assets: -1341124.2647058822
Owner earnings: 1692255.1470588234
Return on net tangible assets (%): -126.18183054274593
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
P/E ratio: 3.3307151916581903
Shares outstanding: 76655311
Book value: -1341124.2647058822
Market cap (USD): 5636419.926470588
Debt to equity: -0.988522031285209
Current ratio: 0.002840702521697533
Quick ratio: 0.002840702521697533
Free cash flow (dilution-adjusted): -68645.58823529411
Buyback yield (%): 0
Retained earnings: -50237469.11764705
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -79585.60606060606
Net income: -53524.242424242424
Capital expenditures: 0
Operating cash flow: -81599.24242424242
Net tangible assets: -740343.9393939393
Owner earnings: -53524.242424242424
Buffett classification: The Gruesome
Stock price: 0.08333333333333333
Shares outstanding: 76655311
Book value: -740343.9393939393
Market cap (USD): 6387942.583333333
Debt to equity: -1.1287556766204079
Current ratio: 0.11955688373513569
Quick ratio: 0.11955688373513569
Free cash flow (dilution-adjusted): -81599.24242424242
Buyback yield (%): 0
Retained earnings: -51813340.90909091
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.029629629629629627
Shares outstanding: 76655311
Market cap (USD): 2271268.474074074
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -294056.6433566434
Net income: -294483.9160839161
Capital expenditures: 0
Operating cash flow: -52313.28671328672
Depreciation & amortization: 0
Net tangible assets: -644311.8881118881
Owner earnings: -294483.9160839161
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 76655311
Book value: -644311.8881118881
Market cap (USD): 2680255.62937063
Debt to equity: -0.6436975100014544
Current ratio: 0.026308809091783344
Quick ratio: 0.026308809091783344
Free cash flow (dilution-adjusted): -52313.28671328672
Buyback yield (%): 0
Retained earnings: -48122183.21678322
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -256407.6923076923
Net income: -256550.34965034967
Capital expenditures: 0
Operating cash flow: -21980.41958041958
Net tangible assets: -644311.8881118881
Owner earnings: -256550.34965034967
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 76655311
Book value: -644311.8881118881
Market cap (USD): 2680255.62937063
Debt to equity: -0.6436975100014544
Current ratio: 0.026308809091783344
Quick ratio: 0.026308809091783344
Free cash flow (dilution-adjusted): -21980.41958041958
Buyback yield (%): 0
Retained earnings: -48122183.21678322
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -143066.43356643358
Net income: -144209.0909090909
Capital expenditures: 0
Operating cash flow: -1228.6713286713286
Depreciation & amortization: 0
Net tangible assets: 2484234.265734266
Owner earnings: -144209.0909090909
Return on net tangible assets (%): -5.804971491545986
Buffett classification: The Gruesome
Stock price: 0.03496503496503497
Shares outstanding: 76655311
Book value: 2484234.2657342656
P/B ratio: 1.0789061508168296
Market cap (USD): 2680255.62937063
Debt to equity: 0.13880006924788635
Current ratio: 4.296669695032151
Quick ratio: 4.296669695032151
Free cash flow (dilution-adjusted): -1228.6713286713286
Buyback yield (%): 0
Retained earnings: -48266392.30769231
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.758975131282453
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -787527.7372262774
Net income: -797440.1459854014
Capital expenditures: 0
Operating cash flow: -1231376.6423357662
Depreciation & amortization: 767.883211678832
Net tangible assets: 2561298.5401459853
Owner earnings: -796672.2627737225
Return on net tangible assets (%): -31.104232883696366
Buffett classification: The Gruesome
Stock price: 0.45985401459854014
Shares outstanding: 76655311
Book value: 2561298.5401459853
P/B ratio: 13.762648887325916
Market cap (USD): 35250252.50364964
Debt to equity: 0.005695958852988291
Current ratio: 6.026177671055975
Quick ratio: 6.026177671055975
Free cash flow (dilution-adjusted): -1696559.8540145983
Buyback yield (%): 0
Retained earnings: -51193924.08759124
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.747205953640645
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1701751.7985611511
Net income: -1685511.510791367
Capital expenditures: 30492.805755395686
Operating cash flow: -1539429.4964028778
Depreciation & amortization: 2755.395683453238
Net tangible assets: 4896120.143884893
Owner earnings: -1713248.9208633094
Return on net tangible assets (%): -34.99197059130802
Buffett classification: The Gruesome
Stock price: 0.525179856115108
Shares outstanding: 76655311
Book value: 4896120.143884893
P/B ratio: 8.22239324574575
Market cap (USD): 40257825.20143885
Debt to equity: 0
Current ratio: 8.99987835711272
Quick ratio: 8.99987835711272
Free cash flow (dilution-adjusted): -1824984.1726618707
Buyback yield (%): 0
Retained earnings: -52134662.58992806
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.75714950922085
Rule of 40 score: 0
Financial ratios for AUX.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -4738340.875912408
Net income: -4724162.04379562
Capital expenditures: 46424.81751824817
Operating cash flow: -4253948.905109488
Depreciation & amortization: 5254.744525547445
Net tangible assets: 3651467.8832116784
Owner earnings: -4765332.116788321
Return on net tangible assets (%): -130.50456060966184
Buffett classification: The Gruesome
Stock price: 0.24817518248175183
Shares outstanding: 76655311
Book value: 3651467.883211679
P/B ratio: 5.209944713764747
Market cap (USD): 19023945.795620438
Debt to equity: 0.00199679720844192
Current ratio: 6.722432417200504
Quick ratio: 6.722432417200504
Free cash flow (dilution-adjusted): -4943375.912408758
Buyback yield (%): 0
Retained earnings: -54953886.131386854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -129.76537183026682
Rule of 40 score: 0
Financial ratios for AUX.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -2074886.1313868612
Net income: -2066079.5620437954
Capital expenditures: 382905.8394160584
Operating cash flow: -1459386.8613138685
Depreciation & amortization: 1691.2408759124087
Net tangible assets: 3651467.8832116784
Owner earnings: -2447294.1605839413
Return on net tangible assets (%): -67.0222014504316
Buffett classification: The Gruesome
Stock price: 0.24817518248175183
Shares outstanding: 76655311
Book value: 3651467.883211679
P/B ratio: 5.209944713764747
Market cap (USD): 19023945.795620438
Debt to equity: 0.00199679720844192
Current ratio: 6.722432417200504
Quick ratio: 6.722432417200504
Free cash flow (dilution-adjusted): -1393907.2992700727
Buyback yield (%): 0
Retained earnings: -54953886.131386854
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.82334331698621
Rule of 40 score: 0
Financial ratios for AVROIND.NS — annual report dated 2022-03-31
Total revenue: 8537623.631807992
Gross profit: 1273493.3403666096
Operating income: 511288.4082816827
Net income: 392456.8112884083
Capital expenditures: 391309.5081102466
Operating cash flow: -76842.93815112753
Depreciation & amortization: 169167.8755110115
Net tangible assets: 2726730.845311882
Owner earnings: 170315.1786891732
Return on net tangible assets (%): 6.246130929350771
Capex to operating income (%): 76.5340073766475
Buffett classification: The Gruesome
Stock price: 0.0811024660424634
P/E ratio: 27.72695262096774
Shares outstanding: 134171400
Book value: 2727746.2745615197
P/B ratio: 3.989238850346877
Market cap (USD): 10881631.412369775
Debt to equity: 0.371514902463197
Current ratio: 1.6176139798857114
Quick ratio: 1.2893493086119583
Effective tax rate (%): 24.178343949044585
Interest coverage ratio: 9.481780386402543
COGS to revenue (%): 85.08374935125916
SG&A to revenue (%): 4.487741887650445
Free cash flow (dilution-adjusted): -497824.08017934853
Buyback yield (%): 0
Retained earnings: 581076.0912567585
Inventory turnover: 10.908999089000671
Receivables turnover: 3.4725295944474546
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.67669399181157
FCF margin (%): -5.830944319501766
Rule of 40 score: -5.830944319501766
Financial ratios for AVROIND.NS — annual report dated 2023-03-31
Total revenue: 9745797.807551768
Gross profit: 1402618.7576126675
Operating income: 552411.6930572473
Net income: 505627.28380024363
Capital expenditures: 614263.0937880634
Operating cash flow: 343520.0974421438
Depreciation & amortization: 221583.4348355664
Net tangible assets: 3025432.3995127897
Owner earnings: 112947.62484774669
Return on net tangible assets (%): 3.733272138750665
Capex to operating income (%): 111.19661323396468
Buffett classification: The Gruesome
Stock price: 0.15091352009744216
P/E ratio: 40.04585772788592
Shares outstanding: 134171400
Book value: 3025615.103532278
P/B ratio: 6.692284899940822
Market cap (USD): 20248278.27040195
Debt to equity: 0.46610548181785244
Current ratio: 1.9434248215449432
Quick ratio: 1.4579134019368623
Effective tax rate (%): 28.77144818119423
Interest coverage ratio: 4.7609699769053115
COGS to revenue (%): 85.60796370589779
SG&A to revenue (%): 3.5019309362228634
Free cash flow (dilution-adjusted): -312460.41412911087
Buyback yield (%): 0
Retained earnings: 1042326.4311814861
Inventory turnover: 10.690874186449408
Receivables turnover: 4.807144659529217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.319840518745888
FCF margin (%): -3.2061040080986833
Revenue growth (%): 14.151176344229679
Rule of 40 score: 10.945072336130995
Financial ratios for AVROIND.NS — annual report dated 2024-03-31
Total revenue: 11196654.275092937
Gross profit: 1601055.2824079625
Operating income: 381136.82695766876
Net income: 484134.78834392613
Capital expenditures: 1084866.2909221728
Operating cash flow: 726537.95419115
Depreciation & amortization: 333864.97181916295
Net tangible assets: 3461062.4775152896
Owner earnings: -266866.5307590838
Return on net tangible assets (%): -7.710537804294949
Capex to operating income (%): 284.6395872007048
Buffett classification: The Gruesome
Stock price: 0.1257197696737044
P/E ratio: 34.84153155467016
Shares outstanding: 134171400
Book value: 3461182.39597074
P/B ratio: 4.873478359428551
Market cap (USD): 16867997.504798464
Debt to equity: 0.5412745818146542
Current ratio: 1.558549292203474
Quick ratio: 1.2304273569696071
Effective tax rate (%): 28.395587244155934
Interest coverage ratio: 2.3219608416130915
COGS to revenue (%): 85.70059195299504
SG&A to revenue (%): 4.29093627535507
Free cash flow (dilution-adjusted): -375368.74925050966
Buyback yield (%): 0
Retained earnings: 1510336.9708598154
Inventory turnover: 11.666598626561884
Receivables turnover: 4.524936634632627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.472815169379883
FCF margin (%): -3.3525081692083765
Revenue growth (%): 14.886995361395023
Rule of 40 score: 11.534487192186646
Financial ratios for AVROIND.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 3613043.4782608696
Buffett classification: The Gruesome
Stock price: 0.19923554706163402
Shares outstanding: 134171400
Book value: 3613043.478260869
P/B ratio: 7.398668861824097
Market cap (USD): 26731712.279025324
Debt to equity: 0.7249077637164281
Current ratio: 1.4704758576946597
Quick ratio: 1.056818829213082
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVROIND.NS — quarterly report dated 2024-12-31
Total revenue: 2805023.8955589226
Gross profit: 728721.2961883668
Operating income: 49994.171814896836
Net income: 120946.49726075299
Capital expenditures: 0
Depreciation & amortization: 126564.86770019816
Owner earnings: 247511.36496095115
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.23953840773982982
P/E ratio: 66.43268769275251
Shares outstanding: 134171400
Market cap (USD): 32139203.520223804
Effective tax rate (%): 26.712812544144654
Interest coverage ratio: 1.0369922630560928
COGS to revenue (%): 74.02085246610125
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVROIND.NS — annual report dated 2025-03-31
Total revenue: 9156511.57353285
Gross profit: 1939805.9387421089
Operating income: 151402.85246668223
Net income: 355646.48117839603
Capital expenditures: 1303904.6060322656
Operating cash flow: -269195.69791910215
Depreciation & amortization: 458300.21042787
Net tangible assets: 9939735.796118774
Owner earnings: -489957.9144259996
Return on net tangible assets (%): -4.929285088415694
Capex to operating income (%): 861.2153501660105
Buffett classification: The Gruesome
Stock price: 0.16898121134321392
P/E ratio: 63.749950862699954
Shares outstanding: 134171400
Book value: 9939735.796118774
P/B ratio: 2.280990779298976
Market cap (USD): 22672445.699614894
Debt to equity: 0.2340842933507401
Current ratio: 3.3330087082564237
Quick ratio: 2.7676099667448035
Effective tax rate (%): 24.238575519860543
Interest coverage ratio: 0.8245893289188845
COGS to revenue (%): 78.81501133740527
SG&A to revenue (%): 6.655874001593364
Free cash flow (dilution-adjusted): -1577191.956979191
Buyback yield (%): 0
Retained earnings: 1828021.978021978
Inventory turnover: 4.1213264257006665
Receivables turnover: 3.33224704425848
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4242698843516166
FCF margin (%): -17.224812575327356
Revenue growth (%): -18.22100291243612
Rule of 40 score: -35.445815487763475
Financial ratios for AVROIND.NS — quarterly report dated 2025-03-31
Total revenue: 2278922.141688099
Gross profit: -198597.14753331774
Operating income: -38391.39583820435
Net income: 60240.82300678045
Capital expenditures: 0
Depreciation & amortization: 139876.08136544307
Net tangible assets: 9939735.796118774
Owner earnings: 200116.9043722235
Return on net tangible assets (%): 2.0133020482331565
Buffett classification: The Gruesome
Stock price: 0.16898121134321392
P/E ratio: 94.09086964608278
Shares outstanding: 134171400
Book value: 9939735.796118774
P/B ratio: 2.280990779298976
Market cap (USD): 22672445.699614894
Debt to equity: 0.2340842933507401
Current ratio: 3.3330087082564237
Quick ratio: 2.7676099667448035
Effective tax rate (%): 23.56867398398101
Interest coverage ratio: -0.7566820276497697
COGS to revenue (%): 108.71452095270828
Buyback yield (%): 0
Retained earnings: 1828021.978021978
Inventory turnover: 1.4148652076963135
Receivables turnover: 0.829347673483627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.36115375648295184
Revenue growth (%): -18.755695974775062
Rule of 40 score: -18.755695974775062
Financial ratios for AVROIND.NS — quarterly report dated 2025-06-30
Total revenue: 2535466.885092441
Gross profit: 868137.1401825416
Operating income: 29651.29885326469
Net income: 123086.82424526096
Capital expenditures: 0
Depreciation & amortization: 120091.27076995086
Owner earnings: 243178.09501521182
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.21799672361338637
P/E ratio: 96.12688468635633
Shares outstanding: 134171400
Market cap (USD): 29248925.60262111
Effective tax rate (%): 26.49196366177498
Interest coverage ratio: 0.6213830308974988
COGS to revenue (%): 65.76026509015558
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.257284253436922
Rule of 40 score: 11.257284253436922
Financial ratios for AVROIND.NS — quarterly report dated 2025-09-30
Total revenue: 2356493.7993235625
Gross profit: 845005.6369785795
Operating income: -16042.841037204058
Net income: 136234.49830890642
Capital expenditures: 0
Depreciation & amortization: 118139.79706877113
Net tangible assets: 9839425.028184893
Owner earnings: 254374.29537767754
Return on net tangible assets (%): 2.5852556897280685
Buffett classification: The Gruesome
Stock price: 0.16933483652762119
P/E ratio: 51.57649561685926
Shares outstanding: 134171400
Book value: 9839425.028184894
P/B ratio: 2.30906704615374
Market cap (USD): 22719892.08568207
Debt to equity: 0.26815711589823965
Current ratio: 1.9253729822619043
Quick ratio: 1.9253729822619043
Effective tax rate (%): 16.37948930869836
Interest coverage ratio: -0.4300392867935932
COGS to revenue (%): 64.14140206008008
Buyback yield (%): 0
Receivables turnover: 0.7600349071868808
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.15007524855224313
Revenue growth (%): -7.058782223549066
Rule of 40 score: -7.058782223549066
Financial ratios for AVROIND.NS — quarterly report dated 2025-12-31
Total revenue: 2705469.533251643
Gross profit: 898908.3212654562
Operating income: -56889.829564442465
Net income: 119004.12164420185
Capital expenditures: 0
Depreciation & amortization: 130789.7961457057
Owner earnings: 249793.91778990754
Buffett classification: The Gruesome
Stock price: 0.13356355129776096
P/E ratio: 40.861347546845664
Shares outstanding: 134171400
Market cap (USD): 17920408.666592404
Effective tax rate (%): 23.730991647033626
Interest coverage ratio: -1.0388527257933278
COGS to revenue (%): 66.7744060608556
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 14.809108940929741
Rule of 40 score: 14.809108940929741
Financial ratios for BLW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.12
Shares outstanding: 39084400
Market cap (USD): 434618527.99999994
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLW — annual report dated 2022-12-31
Total revenue: -65553040
Net income: -66022789
Capital expenditures: 0
Operating cash flow: 74392732
Net tangible assets: 482587203
Owner earnings: -66022789
Return on net tangible assets (%): -13.681006995123324
Buffett classification: The Gruesome
Stock price: 9.35
Shares outstanding: 39084400
Book value: 482587203
P/B ratio: 0.7572499596513337
Market cap (USD): 365439140
Debt to equity: 0.5711688960803215
Free cash flow (dilution-adjusted): 74392732
Buyback yield (%): 0
Retained earnings: -135532393
Receivables turnover: -3.680250831568991
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLW — annual report dated 2023-12-31
Total revenue: 64794314
Net income: 64272023
Capital expenditures: 0
Operating cash flow: 38703003
Net tangible assets: 503770023
Owner earnings: 64272023
Return on net tangible assets (%): 12.758207131352078
Buffett classification: The Gruesome
Stock price: 10.96
P/E ratio: 6.664875384426597
Shares outstanding: 39084400
Book value: 503770023
P/B ratio: 0.8503186065916432
Market cap (USD): 428365024.00000006
Debt to equity: 0.5483363189317837
COGS to revenue (%): 0
SG&A to revenue (%): 0.6874322336370442
Free cash flow (dilution-adjusted): 38703003
Buyback yield (%): 0
Retained earnings: -109252919
Receivables turnover: 3.5865394440486726
Capitalized R&D asset: 0
FCF margin (%): 59.73209778870411
Rule of 40 score: 59.73209778870411
Financial ratios for BLW — annual report dated 2024-12-31
Total revenue: 45601787
Net income: 45017449
Capital expenditures: 0
Operating cash flow: -27404519
Net tangible assets: 514290737
Owner earnings: 45017449
Return on net tangible assets (%): 8.753307372907242
Buffett classification: The Gruesome
Stock price: 12.17
P/E ratio: 10.56606179528298
Shares outstanding: 39084400
Book value: 514290737
P/B ratio: 0.9248798661524406
Market cap (USD): 475657148
Debt to equity: 0.6565862978006544
COGS to revenue (%): 0
SG&A to revenue (%): 1.1244186549092912
Free cash flow (dilution-adjusted): -27404519
Buyback yield (%): 0
Retained earnings: -106541718
Receivables turnover: 2.987557441894121
Capitalized R&D asset: 0
FCF margin (%): -60.095274336507906
Revenue growth (%): -29.62069634690476
Rule of 40 score: -89.71597068341266
Financial ratios for BLW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 514290737
Buffett classification: The Gruesome
Stock price: 12.17
Shares outstanding: 39084400
Book value: 514290737
P/B ratio: 0.9248798661524406
Market cap (USD): 475657148
Debt to equity: 0.6565862978006544
Buyback yield (%): 0
Retained earnings: -106541718
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 539365366
Buffett classification: The Gruesome
Stock price: 12.82
Shares outstanding: 39084400
Book value: 539365366
P/B ratio: 0.9289843945968158
Market cap (USD): 501062008
Debt to equity: 0.611644699114774
Buyback yield (%): 0
Retained earnings: -108509561
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTL.AX — annual report dated 2021-12-31
Total revenue: 6161151.449275363
Gross profit: 2534213.7681159424
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24637681159420294
Shares outstanding: 1507187836
Market cap (USD): 371336133.50724643
COGS to revenue (%): 58.86785467002274
Buyback yield (%): 0.36264128223216674
Inventory turnover: 112.21356828983947
Receivables turnover: 2.7624424436262696
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTL.AX — annual report dated 2022-12-31
Total revenue: 9446585.135135135
Gross profit: 5419102.702702703
Operating income: -3103511.4864864866
Net income: -4056220.2702702703
Capital expenditures: 154914.86486486485
Depreciation & amortization: 734920.9459459459
Net tangible assets: 90207500.67567568
Owner earnings: -3476214.189189189
Return on net tangible assets (%): -3.8535755487642565
Buffett classification: The Gruesome
Stock price: 0.13513513513513514
Shares outstanding: 1507187836
Book value: 90275533.78378378
P/B ratio: 2.2561376638293327
Market cap (USD): 203674031.8918919
Debt to equity: 0.06609704419180948
Current ratio: 1.1984006515355523
Quick ratio: 1.1959377601542915
Interest coverage ratio: -2.01409719871398
COGS to revenue (%): 42.63426809602155
SG&A to revenue (%): 25.667512055335884
Free cash flow (dilution-adjusted): -21949518.91891892
Buyback yield (%): 0
Retained earnings: -89687614.86486487
Inventory turnover: 89.82194361145854
Receivables turnover: 1.4438622912957206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.690703973724578
FCF margin (%): -232.35400522968902
Revenue growth (%): 53.32499473367408
Rule of 40 score: -179.02901049601493
Financial ratios for BTL.AX — annual report dated 2023-12-31
Total revenue: 4168169.8630136987
Gross profit: 132217.12328767125
Operating income: -12864736.98630137
Net income: -15124600
Capital expenditures: 182826.71232876714
Depreciation & amortization: 1019199.3150684931
Net tangible assets: 76851839.0410959
Owner earnings: -14288227.397260275
Return on net tangible assets (%): -18.59191344740594
Buffett classification: The Gruesome
Stock price: 0.13013698630136986
Shares outstanding: 1507187836
Book value: 79504160.2739726
P/B ratio: 2.4670518132789363
Market cap (USD): 196140882.76712328
Debt to equity: 0.08396276393703668
Current ratio: 1.3202911430008866
Quick ratio: 1.3181415394963765
Interest coverage ratio: -5.164999632888666
COGS to revenue (%): 96.8279334184314
SG&A to revenue (%): 128.36808901380454
Free cash flow (dilution-adjusted): -6598493.835616439
Buyback yield (%): 0
Retained earnings: -106040812.32876712
Inventory turnover: 151.33397539615277
Receivables turnover: 3.182441350890588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.951064743995813
FCF margin (%): -158.30674018754002
Revenue growth (%): -55.87643785148534
Rule of 40 score: -214.18317803902536
Financial ratios for BTL.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 84747322.36024845
Buffett classification: The Gruesome
Stock price: 0.13664596273291924
Shares outstanding: 1507187836
Book value: 84747322.36024845
P/B ratio: 2.430178643215382
Market cap (USD): 205951132.8695652
Debt to equity: 0.016703083654838937
Current ratio: 1.4415456171128782
Quick ratio: 1.4415456171128782
Buyback yield (%): 0
Retained earnings: -105111108.69565217
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BTL.AX — annual report dated 2024-12-31
Operating income: -13444027.329192545
Net income: -8961367.080745341
Capital expenditures: 585334.7826086956
Depreciation & amortization: 174291.9254658385
Net tangible assets: 84747322.36024845
Owner earnings: -9372409.937888198
Return on net tangible assets (%): -11.059240194100123
Buffett classification: The Gruesome
Stock price: 0.13664596273291924
Shares outstanding: 1507187836
Book value: 84747322.36024845
P/B ratio: 2.430178643215382
Market cap (USD): 205951132.8695652
Debt to equity: 0.016703083654838937
Current ratio: 1.4415456171128782
Quick ratio: 1.4415456171128782
Interest coverage ratio: -17.143321949272288
Free cash flow (dilution-adjusted): -23771748.447204966
Buyback yield (%): 0.4660096599327192
Retained earnings: -105111108.69565217
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.37189376801906
Rule of 40 score: 0
Financial ratios for CLS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.13
Shares outstanding: 114973107
Market cap (USD): 1279650680.91
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLS — annual report dated 2022-12-31
Total revenue: 5330882352.941176
Gross profit: 477720588.2352941
Operating income: 217647058.8235294
Net income: 132426470.58823529
Capital expenditures: 80147058.8235294
Operating cash flow: 155220588.2352941
Depreciation & amortization: 85220588.23529412
Net tangible assets: 736838235.2941176
Owner earnings: 137500000
Return on net tangible assets (%): 18.660812294182218
Capex to operating income (%): 36.82432432432432
Buffett classification: The Good
Stock price: 11.27
P/E ratio: 9.784651891229316
Shares outstanding: 114973107
Book value: 1233602941.1764703
P/B ratio: 1.0503759942840796
Market cap (USD): 1295746915.8899999
Debt to equity: 0.46855814507957333
Current ratio: 1.4162738936894474
Quick ratio: 0.6469952867242733
Effective tax rate (%): 24.675867837724798
Interest coverage ratio: 5.725338491295938
COGS to revenue (%): 91.03862068965518
R&D to revenue (%): 0.6386206896551724
SG&A to revenue (%): 3.686896551724138
Free cash flow (dilution-adjusted): 37573529.411764696
Buyback yield (%): 1.963437161886945
Retained earnings: -791617647.0588235
Inventory turnover: 2.808279794068842
Receivables turnover: 5.180791767900529
Capitalized R&D asset: 34044117.64705882
ROCI (R&D-adjusted, %): 12.480114034082955
FCF margin (%): 0.7048275862068963
Rule of 40 score: 0.7048275862068963
Financial ratios for CLS — annual report dated 2023-12-31
Total revenue: 6031060606.060606
Gross profit: 571287878.7878788
Operating income: 265454545.45454544
Net income: 185151515.15151516
Capital expenditures: 94772727.27272727
Operating cash flow: 247121212.1212121
Depreciation & amortization: 99090909.0909091
Net tangible assets: 851590909.090909
Owner earnings: 189469696.969697
Return on net tangible assets (%): 22.248910239302557
Capex to operating income (%): 35.70205479452055
Buffett classification: The Good
Stock price: 29.28
P/E ratio: 18.18193370011129
Shares outstanding: 114973107
Book value: 1341666666.666667
P/B ratio: 2.5091273835726704
Market cap (USD): 3366412572.96
Debt to equity: 0.3813099943534725
Current ratio: 1.400589970501475
Quick ratio: 0.7471821145784817
Effective tax rate (%): 20.130718954248366
Interest coverage ratio: 4.44106463878327
COGS to revenue (%): 90.52757191307624
R&D to revenue (%): 0.7649792739605576
SG&A to revenue (%): 3.808566762969476
Free cash flow (dilution-adjusted): 110227272.72727272
Buyback yield (%): 0.8011405727962573
Retained earnings: -645303030.3030303
Inventory turnover: 3.4248443662975814
Receivables turnover: 4.404182341225935
Capitalized R&D asset: 68945922.45989305
ROCI (R&D-adjusted, %): 13.618957428526251
Rosenberg metric: 2.7484128542443873
FCF margin (%): 1.827659841728426
Revenue growth (%): 13.13437826541275
Rule of 40 score: 14.962038107141176
Financial ratios for CLS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.12
Shares outstanding: 114973107
Market cap (USD): 5877425229.84
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 92.3
Shares outstanding: 114973107
Market cap (USD): 10612017776.1
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLS — annual report dated 2024-12-31
Total revenue: 6745454545.454546
Gross profit: 722867132.8671329
Operating income: 432657342.6573427
Net income: 299300699.3006993
Capital expenditures: 119510489.51048951
Operating cash flow: 331398601.3986014
Depreciation & amortization: 106223776.22377622
Net tangible assets: 867762237.7622378
Owner earnings: 286013986.013986
Return on net tangible assets (%): 32.95994842453058
Capex to operating income (%): 27.622434136091805
Buffett classification: The Good
Stock price: 92.3
P/E ratio: 35.45604070052103
Shares outstanding: 114973107
Book value: 1325874125.874126
P/B ratio: 8.003789778387658
Market cap (USD): 10612017776.1
Debt to equity: 0.4202004219409282
Current ratio: 1.4934136493016483
Quick ratio: 0.9107036473158138
Effective tax rate (%): 19.579105599398723
Interest coverage ratio: 11.875239923224568
COGS to revenue (%): 89.28364088741448
R&D to revenue (%): 0.8086253369272237
SG&A to revenue (%): 3.0427120049761562
Free cash flow (dilution-adjusted): 171748251.74825174
Buyback yield (%): 1.0016352077085389
Retained earnings: -296363636.3636364
Inventory turnover: 4.891684652959218
Receivables turnover: 4.662155630739488
Capitalized R&D asset: 96691377.0053476
ROCI (R&D-adjusted, %): 20.36929629110686
Rosenberg metric: 3.2854616647720114
FCF margin (%): 2.5461331121708475
Revenue growth (%): 11.84524557216431
Rule of 40 score: 14.391378684335159
Financial ratios for CLS — quarterly report dated 2025-03-31
Total revenue: 1852167832.1678321
Gross profit: 191538461.53846154
Operating income: 92797202.7972028
Net income: 60279720.279720284
Capital expenditures: 25664335.664335664
Operating cash flow: 91118881.11888112
Depreciation & amortization: 26153846.153846156
Net tangible assets: 642517482.5174825
Owner earnings: 60769230.76923077
Return on net tangible assets (%): 9.457988680888114
Capex to operating income (%): 27.65636774679729
Buffett classification: The Good
Stock price: 78.81
P/E ratio: 37.5791000713982
Shares outstanding: 114973107
Book value: 1088671328.6713285
P/B ratio: 8.323017538937629
Market cap (USD): 9061030562.67
Debt to equity: 0.6048946557040082
Current ratio: 1.4329447973282692
Quick ratio: 0.8474232204832689
Effective tax rate (%): 24.186455584872473
Interest coverage ratio: 9.686131386861312
COGS to revenue (%): 89.65868760854792
R&D to revenue (%): 0.6645020010571623
SG&A to revenue (%): 4.247526995393793
Free cash flow (dilution-adjusted): 47272727.27272728
Buyback yield (%): 0.5996631835623489
Retained earnings: -236083916.0839161
Inventory turnover: 1.327909187496505
Receivables turnover: 1.2400393276838801
Capitalized R&D asset: 12307692.307692308
ROCI (R&D-adjusted, %): 5.161467081204065
FCF margin (%): 2.5522917767877376
Rule of 40 score: 2.5522917767877376
Financial ratios for CLS — quarterly report dated 2025-06-30
Total revenue: 2111970802.9197078
Gross profit: 270802919.70802915
Operating income: 209489051.0948905
Net income: 154014598.54014596
Capital expenditures: 23722627.737226274
Operating cash flow: 111240875.91240875
Depreciation & amortization: 33065693.430656932
Net tangible assets: 825036496.3503649
Owner earnings: 163357664.23357663
Return on net tangible assets (%): 19.800053083252234
Capex to operating income (%): 11.324041811846689
Buffett classification: The Great
Stock price: 156.11
P/E ratio: 83.75607824142692
Shares outstanding: 114973107
Book value: 1283138686.1313868
P/B ratio: 13.987928138838901
Market cap (USD): 17948451733.77
Debt to equity: 0.4978667728539735
Current ratio: 1.4367019995181882
Quick ratio: 0.8591002168152252
Effective tax rate (%): 17.994558880684025
Interest coverage ratio: 21.25925925925926
COGS to revenue (%): 87.17771479919818
R&D to revenue (%): 1.175088131609871
SG&A to revenue (%): 1.3444390682242346
Free cash flow (dilution-adjusted): 76423357.66423357
Buyback yield (%): 0.1626718600860514
Retained earnings: -92408759.12408759
Inventory turnover: 1.3150513529013086
Receivables turnover: 1.2647084535361481
Capitalized R&D asset: 33063672.09432903
ROCI (R&D-adjusted, %): 10.252442600483846
Rosenberg metric: 6.440237226277368
FCF margin (%): 3.61858021704569
Revenue growth (%): 14.026967008048864
Rule of 40 score: 17.645547225094553
Financial ratios for CLS — quarterly report dated 2025-09-30
Total revenue: 2297841726.6187053
Gross profit: 299352517.98561156
Operating income: 237338129.4964029
Net income: 192661870.50359714
Capital expenditures: 26834532.374100722
Operating cash flow: 90791366.90647483
Depreciation & amortization: 28992805.755395684
Net tangible assets: 1016187050.3597122
Owner earnings: 194820143.8848921
Return on net tangible assets (%): 19.171681415929207
Capex to operating income (%): 11.306456501970295
Buffett classification: The Great
Stock price: 246.38
P/E ratio: 69.60718339178429
Shares outstanding: 114973107
Book value: 1459424460.431655
P/B ratio: 19.40975697658355
Market cap (USD): 28327074102.66
Debt to equity: 0.3865227250320418
Current ratio: 1.4684064757445108
Quick ratio: 0.8840190731804813
Effective tax rate (%): 13.862978449662272
Interest coverage ratio: 25.7734375
COGS to revenue (%): 86.97244834063869
R&D to revenue (%): 1.1396368190356918
SG&A to revenue (%): 1.2022542266750156
Free cash flow (dilution-adjusted): 52733812.94964029
Buyback yield (%): 0
Retained earnings: 101582733.81294964
Inventory turnover: 1.3572580251135975
Receivables turnover: 1.309392038699627
Capitalized R&D asset: 46876326.047528066
ROCI (R&D-adjusted, %): 10.631302825191897
Rosenberg metric: 1.1503808717731736
FCF margin (%): 2.2949279899812143
Revenue growth (%): 8.800828280487544
Rule of 40 score: 11.095756270468758
Financial ratios for CLS — quarterly report dated 2025-12-31
Total revenue: 2667810218.978102
Gross profit: 316131386.8613138
Operating income: 234160583.9416058
Net income: 195255474.45255473
Capital expenditures: 69124087.59124087
Operating cash flow: 182919708.02919707
Depreciation & amortization: 38467153.28467153
Net tangible assets: 1175766423.357664
Owner earnings: 164598540.14598536
Return on net tangible assets (%): 13.999255028557236
Capex to operating income (%): 29.519950124688283
Buffett classification: The Good
Stock price: 295.61
P/E ratio: 56.43729971479087
Shares outstanding: 114973107
Book value: 1617737226.2773724
P/B ratio: 21.00909814536385
Market cap (USD): 33987200160.27
Debt to equity: 0.3503587059513603
Current ratio: 1.4400446745862525
Quick ratio: 0.8846583409483197
Effective tax rate (%): 11.21805509459011
Interest coverage ratio: 25.46031746031746
COGS to revenue (%): 88.15015458699278
R&D to revenue (%): 0.8262879969356205
SG&A to revenue (%): 1.9179731319598345
Free cash flow (dilution-adjusted): 104306569.3430657
Buyback yield (%): 0.07667119985671961
Retained earnings: 298321167.8832117
Inventory turnover: 1.472486288848263
Receivables turnover: 1.3854289071680377
Capitalized R&D asset: 47778900.38334296
ROCI (R&D-adjusted, %): 9.513187444617358
Rosenberg metric: 0.6407315312424764
FCF margin (%): 3.909819694109278
Revenue growth (%): 16.100695190343195
Rule of 40 score: 20.010514884452473
Financial ratios for CLS — annual report dated 2025-12-31
Total revenue: 9044452554.744524
Gross profit: 1090583941.6058393
Operating income: 781313868.6131387
Net income: 607664233.5766423
Capital expenditures: 146861313.86861312
Operating cash flow: 481386861.3138686
Depreciation & amortization: 128248175.18248174
Net tangible assets: 1175766423.357664
Owner earnings: 589051094.8905109
Return on net tangible assets (%): 50.09932952570152
Capex to operating income (%): 18.796711509715994
Buffett classification: The Great
Stock price: 295.61
P/E ratio: 55.930887951435324
Shares outstanding: 114973107
Book value: 1617737226.2773724
P/B ratio: 21.00909814536385
Market cap (USD): 33987200160.27
Debt to equity: 0.3503587059513603
Current ratio: 1.4400446745862525
Quick ratio: 0.8846583409483197
Effective tax rate (%): 15.327502034174126
Interest coverage ratio: 20.34980988593156
COGS to revenue (%): 87.94195740422407
R&D to revenue (%): 0.9539258649492774
SG&A to revenue (%): 2.0975070414578445
Free cash flow (dilution-adjusted): 283576642.33576643
Buyback yield (%): 0.3294499175916187
Retained earnings: 298321167.8832117
Inventory turnover: 4.9802559414990855
Receivables turnover: 4.696903074182177
Capitalized R&D asset: 138047826.80822825
ROCI (R&D-adjusted, %): 31.86085132382544
Rosenberg metric: 6.741474826876283
FCF margin (%): 3.1353654698205946
Revenue growth (%): 34.08218073071396
Rule of 40 score: 37.21754620053455
Financial ratios for CMW.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.44360902255639095
Shares outstanding: 2618866699
Market cap (USD): 1161752896.5488722
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMW.AX — annual report dated 2022-06-30
Total revenue: 243103448.27586207
Gross profit: 193172413.79310346
Operating income: 103931034.48275863
Net income: 181517241.37931034
Capital expenditures: 413793.1034482759
Depreciation & amortization: 4137931.034482759
Net tangible assets: 1868896551.724138
Owner earnings: 185241379.31034482
Return on net tangible assets (%): 9.911804863648104
Capex to operating income (%): 0.3981420039814201
Buffett classification: The Great
Stock price: 0.37931034482758624
P/E ratio: 5.472555791983283
Shares outstanding: 2618866699
Book value: 1869241379.3103447
P/B ratio: 0.5314258723620131
Market cap (USD): 993363230.6551725
Debt to equity: 0.8086260330578513
Current ratio: 1.445711028783129
Quick ratio: 1.445711028783129
Effective tax rate (%): 8.38844413505047
Interest coverage ratio: 2.0843706777316737
COGS to revenue (%): 20.53900709219858
SG&A to revenue (%): 32.08510638297872
Free cash flow (dilution-adjusted): 120275862.06896552
Buyback yield (%): 0.034713141735623294
Retained earnings: 318482758.6206897
Receivables turnover: 9.227748691099476
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.204133268130887
FCF margin (%): 49.47517730496454
Rule of 40 score: 49.47517730496454
Financial ratios for CMW.AX — annual report dated 2023-06-30
Total revenue: 231390728.47682118
Gross profit: 178079470.19867548
Operating income: 94503311.25827815
Net income: -293907284.7682119
Capital expenditures: 794701.9867549669
Depreciation & amortization: 4966887.417218543
Net tangible assets: 1464834437.0860927
Owner earnings: -289735099.3377483
Return on net tangible assets (%): -19.779375197793748
Capex to operating income (%): 0.8409250175192713
Buffett classification: The Great
Stock price: 0.2847682119205298
Shares outstanding: 2618866699
Book value: 1465033112.5827816
P/B ratio: 0.5090465059985535
Market cap (USD): 745769987.1324503
Debt to equity: 0.8245637826597956
Current ratio: 1.0255451713395638
Quick ratio: 1.0255451713395638
Interest coverage ratio: 1.6748826291079812
COGS to revenue (%): 23.039496279336007
SG&A to revenue (%): 31.081854607899256
Free cash flow (dilution-adjusted): 97947019.86754967
Buyback yield (%): 0.1420816964062721
Retained earnings: -83443708.60927153
Receivables turnover: 8.460048426150122
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6639535779392505
FCF margin (%): 42.329708070978825
Revenue growth (%): -4.817998215208307
Rule of 40 score: 37.51170985577052
Financial ratios for CMW.AX — annual report dated 2024-06-30
Total revenue: 125133333.33333333
Gross profit: 102066666.66666667
Operating income: 69066666.66666667
Net income: -354400000
Capital expenditures: 3200000
Depreciation & amortization: 1600000
Net tangible assets: 1059666666.6666666
Owner earnings: -356000000
Return on net tangible assets (%): -33.59547027367097
Capex to operating income (%): 4.633204633204633
Buffett classification: The Great
Stock price: 0.22666666666666668
Shares outstanding: 2618866699
Book value: 1059866666.6666666
P/B ratio: 0.5600796815071079
Market cap (USD): 593609785.1066667
Debt to equity: 0.8734432004025664
Current ratio: 2.8854850474106493
Quick ratio: 2.8854850474106493
Interest coverage ratio: 1.3943472409152087
COGS to revenue (%): 18.433670751198722
SG&A to revenue (%): 22.216302610548748
Free cash flow (dilution-adjusted): 72066666.66666667
Buyback yield (%): 0.05615361163115532
Retained earnings: -492066666.6666667
Receivables turnover: 7.275193798449612
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6884078610082605
FCF margin (%): 57.5919019712307
Revenue growth (%): -45.921198244609805
Rule of 40 score: 11.670703726620893
Financial ratios for CRDL.L — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0018055555555555555
Shares outstanding: 216923230
Market cap (USD): 391666.9430555555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CRDL.L — annual report dated 2022-06-30
Total revenue: 2771564.6341463416
Gross profit: -489819.51219512196
Operating income: -1451692.6829268294
Net income: -1464259.756097561
Capital expenditures: 180181.7073170732
Operating cash flow: -1255206.0975609757
Depreciation & amortization: 203410.9756097561
Net tangible assets: 1843742.6829268294
Owner earnings: -1441030.487804878
Return on net tangible assets (%): -78.15789595527124
Buffett classification: The Gruesome
Stock price: 0.0006097560975609756
Shares outstanding: 216923230
Book value: 3335697.5609756103
P/B ratio: 0.03965295407549962
Market cap (USD): 132270.26219512196
Debt to equity: 0.03923522048264304
Current ratio: 2.4222262251980515
Quick ratio: 2.106749145002689
Interest coverage ratio: -82.67731629392972
COGS to revenue (%): 117.67303227066863
SG&A to revenue (%): 25.83571927981157
Free cash flow (dilution-adjusted): -1530350
Buyback yield (%): 0
Retained earnings: -13285830.487804879
Inventory turnover: 10.829897950919252
Receivables turnover: 3.5477522564853463
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -42.471158460333626
FCF margin (%): -55.21610360969832
Rule of 40 score: -55.21610360969832
Financial ratios for CRDL.L — annual report dated 2023-06-30
Total revenue: 3856324.0506329113
Gross profit: 198413.9240506329
Operating income: -568115.1898734177
Net income: -757151.8987341772
Capital expenditures: 10902.53164556962
Operating cash flow: -796396.2025316455
Depreciation & amortization: 148483.54430379745
Net tangible assets: 3260345.569620253
Owner earnings: -619570.8860759494
Return on net tangible assets (%): -19.00322750597611
Buffett classification: The Gruesome
Stock price: 0.0007594936708860758
Shares outstanding: 216923230
Book value: 4808956.9620253155
P/B ratio: 0.034259366751283736
Market cap (USD): 164751.82025316454
Debt to equity: 0.008607356104484355
Current ratio: 3.33876000688646
Quick ratio: 3.198114831712146
Interest coverage ratio: -26.684761281883585
COGS to revenue (%): 94.8548430721721
Free cash flow (dilution-adjusted): -945977.2151898735
Buyback yield (%): 0
Retained earnings: -14544015.189873418
Inventory turnover: 20.0982675040513
Receivables turnover: 2.1917442393346125
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.807376114379311
FCF margin (%): -24.530542629959143
Revenue growth (%): 39.138882172260146
Rule of 40 score: 14.608339542301003